TY - JOUR T1 - Chronic Constipation: Mechanisms and Roadmap for Testing Candidate Endotypes AU - Bonora, Elena AU - Boschetti, Elisa AU - Parmar, Visha AU - Arumugam, Saranya AU - De Giorgio, Roberto AU - Srinivasan, Shanthi AU - Wiley, John W. JF - Journal of Translational Gastroenterology VL - IS - 000 SN - 2994-8754 SP - EP - Y1 - 2026-12-30 DO - 10.14218/JTG.2026.00033 UR - https://www.xiahepublishing.com/2994-8754/JTG-2026-00033 AB - Chronic constipation is common, heterogeneous, and often incompletely controlled. This review evaluates cellular and molecular evidence and proposes a roadmap for testing candidate endotypes. We distinguish established physiology and clinical efficacy from human associations, causal effects in experimental systems, and unvalidated hypotheses. Relevant mechanisms involve enteric neurons and glia, pacemaker and smooth muscle networks, epithelial transport, enteroendocrine signaling, microbial metabolites, and pelvic floor coordination. Five candidate endotypes address neuronal composition, pacemaker dysfunction, methanogen enrichment, neuroimmune activation, and cortical–pelvic coordination; pharmacogenomics provides a cross-cutting strategy. Each proposal links measurable features to appropriate sampling and prospective tests that can exclude clinically meaningful effects. Cellular sequencing, spatial RNA and protein profiling, and multimodal integration can identify candidate signatures. Organoid and animal perturbations test mechanisms within models; clinical usefulness additionally requires reproducible assays, independent validation, randomized treatment-interaction tests, and patient benefit. Rome V criteria provide a cohort framework, with the criteria version recorded explicitly. A staged program should begin with clinical phenotyping and biospecimen banking, add mucosal studies, and develop multicenter full-thickness tissue collections for neuromuscular questions. This approach addresses cost, selection bias, and tissue access while distinguishing mechanistic discovery from useful treatment guidance.